At a glance
XHS charges 0.35% a year, above the 0.31% average of the 6 funds most like it (the 4th cheapest of 7). It has $139.9M in assets, the 7th largest of that group; it paid 0.15% of its price in distributions over the past 12 months, quarterly. Over the past year it returned +33.7% with distributions reinvested (S&P 500: +11.5%), the best of those 7 funds; over three years it returned +22.1% a year. At its worst it fell 27.2% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 41 months after the low. Its ten largest positions make up 20.4% of the fund, out of 61 in all.
The short version
SPDR S&P Health Care Services ETF (XHS), from State Street, tracks the S&P Health Care Services Select Industry Index: about 60 U.S. health care providers, managed care companies, distributors and service firms. The index is modified equal weighted, so smaller companies count about as much as larger ones. No holding was above about 2.2% as of June 30, 2026. Its 0.35% expense ratio is well above broad health care funds such as VHT (0.09%).
Price history
The interactive chart needs JavaScript.
XHS +33.7% over the year to Oct 27, 2026, total return with distributions reinvested.
How it has behaved
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | Since start | |
|---|---|---|---|---|---|---|
| XHS official prospectus, to Dec 31, 2025 | — | +18.74% | — | +2.27% | +6.93% | — |
| XHS price data to Oct 27, 2026 | +32.0% | +33.7% | +22.1% | +6.8% | — | +11.7% |
- Over the year to Oct 27, 2026, XHS returned +33.7%, 1st of 7 among similar funds.
- Its 5-year annualized return was +6.8%.
- Its worst full calendar year was 2022 (-19.9%); its best was 2025 (+18.8%).
- The deepest fall in its price history was 32.6% (Jun 28, 2021 to Jun 16, 2022), recovered by May 27, 2026.
Show as a table
| Year | Price data | Prospectus (official) |
|---|---|---|
| 2026 (to date) | +32.0% | — |
| 2025 | +18.8% | +18.74% |
| 2024 | +1.8% | +1.86% |
| 2023 | +5.2% | +5.12% |
| 2022 | -19.9% | -19.86% |
| 2021 | +9.8% | +9.83% |
| 2020 | — | +33.33% |
| 2019 | — | +18.74% |
| 2018 | — | +2.61% |
| 2017 | — | +17.12% |
| 2016 | — | -8.19% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Not in the price data, which starts Jun 2, 2020 |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 17.5% over that stretch · deepest drop along the way 27.2%, back to its old high 41.2 months after the low |
Dividends and income
Show as a table
| Year | Per share | Change |
|---|---|---|
| 2026 (to date) | $0.0900 | |
| 2025 | $0.2900 | -12.1% |
| 2024 | $0.3300 | +65.0% |
| 2023 | $0.2000 | +25.0% |
| 2022 | $0.1600 | -23.8% |
| 2021 | $0.2100 |
What's inside
As of Jun 30, 2026, the fund held 61 securities; the ten largest made up 20.35% of assets.
| Holding | Weight | |
|---|---|---|
| LifeStance Health Group Inc | 2.20% | |
| Hinge Health Inc | 2.16% | |
| NeoGenomics Inc | 2.09% | |
| GeneDx Holdings Corp | 2.04% | |
| Hims & Hers Health Inc | 2.02% | |
| PACS Group Inc | 2.01% | |
| Acadia Healthcare Co Inc | 2.00% | |
| Brookdale Senior Living Inc | 1.98% | |
| Astrana Health Inc | 1.94% | |
| Surgery Partners Inc | 1.91% | |
| Alignment Healthcare Inc | 1.87% | |
| Molina Healthcare Inc | 1.87% | |
| BrightSpring Health Services Inc | 1.86% | |
| Guardant Health Inc | 1.85% | |
| Sonida Senior Living Inc | 1.84% |
By country
United States 99.95%By asset type
Stocks 99.95%What changed recently
- Over the three months to Jun 30, 2026, investors added a net $28.7M (creations minus redemptions, per the N-PORT report).
- Monthly total returns reported for that quarter: +9.62%, +4.22%, +15.19%.
How it works
The fund follows an index run by S&P Dow Jones Indices. The index covers the health care services part of the S&P Total Market Index, which tracks the broad U.S. stock market. Only four industry groups qualify: health care distributors, health care facilities, health care services and managed health care. A company must be based in the U.S. and pass size and trading tests. Generally it needs a float-adjusted market value of at least $500 million, which counts only the shares the public can trade. Existing members are removed if their value falls below $300 million or their shares trade too little. As of July 31, 2026, the index held 60 stocks.
The index is modified equal weighted. Each company gets roughly the same weight instead of a weight based on its size. The index rebalances and reconstitutes every quarter, on the third Friday of March, June, September and December. A second reweighting follows late in each of those months. Bringing every stock back toward equal weight means trimming winners and adding to laggards. That helps explain the fund's 49% portfolio turnover.
SSGA Funds Management, the adviser, may use sampling. That means it can hold a representative subset of the index instead of every stock. However, it must keep at least 80% of net assets in index securities. It may use futures to manage cash flows. As of June 30, 2026, the fund held 61 stocks, no derivatives and 0.21% in cash.
What it really costs
- XHS charges 0.35% a year, versus an average of 0.31% for the similar funds below (4th of 7, cheapest first).
- Using the prospectus's standard example, $10,000 invested would cost about $36 in the first year and $443 over 10 years (assuming a 5% annual return).
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| XHS | $36 | $113 | $197 | $443 |
In a retirement portfolio
It holds one narrow slice of health care with roughly equal weights in mostly smaller companies, and its losses have taken years to recover.
XHS could add focused exposure to U.S. health care providers and services, a group shaped heavily by government reimbursement and regulation. Its history shows deep, slow-to-heal drops. The fund started in 2011, after the 2008 crisis. It lost 20.68% in the first quarter of 2020. In the 2022 bear market it fell 27.2% between January 3 and June 16, 2022, and it took about 41 months to recover, until November 2025. Its deepest drop, 32.6% from June 2021 to June 2022, took about 47 months to make back. Its worst calendar year was 2022, at -19.86%. Anyone forced to sell during stretches like these would lock in losses. Income is small: the yield was 0.15% as of October 27, 2026, paid quarterly. On $10,000, costs come to about $36 in year one and $443 over 10 years. Past results don't predict the future, and a plan should look at the whole portfolio, not one fund.
Who it may suit — and who should look elsewhere
May suit
- Investors who want a targeted slice of U.S. health care providers, insurers, labs and senior living operators rather than drug or device makers.
- Those who prefer evenly spread positions: no holding topped about 2.2%, and the top 10 made up about 20% as of June 30, 2026.
- Holders who keep it a small position and can sit through drops like the 32.6% fall that took about 47 months to recover.
Look elsewhere if
- Income seekers: the trailing yield was just 0.15% as of October 27, 2026, paid quarterly.
- Cost-focused investors wanting all of health care: VHT charges 0.09% and FHLC 0.084%, compared with 0.35% for XHS.
- Those who want a larger fund: at about $140 million in net assets as of June 30, 2026, XHS was the smallest of its compared peers.
Close alternatives
Matched by closest holdings overlap from the latest N-PORT reports (no similar fund shares 20% or more of its holdings).
| Fund | Overlap | Cost | Net assets | 1 yr | 3 yr |
|---|---|---|---|---|---|
| XHS this fund | — | 0.35% | $139.9M | +33.7% | +22.1% |
| IHF iShares U.S. Healthcare Providers ETF | 39% | 0.4% | $1.18B | +16.5% | +7.7% |
| RSPH Invesco S&P 500 Equal Weight Health Care ETF | 24% | 0.4% | $766.9M | +28.4% | +16.6% |
| FXH First Trust Health Care AlphaDEX Fund | 20% | 0.6% | $1.05B | +19.7% | +15.1% |
| PSCH Invesco S&P SmallCap Health Care ETF | 18% | 0.29% | $183.9M | +28.0% | +16.4% |
| FHLC Fidelity MSCI Health Care Index ETF | 14% | 0.084% | $3.29B | +23.8% | +16.0% |
| VHT Vanguard Health Care ETF | 14% | 0.09% | $22.04B | +28.9% | +16.9% |
Questions investors ask
Is XHS good for retirement?
XHS fits more naturally as a small, higher-risk add-on than as a core retirement holding. It holds about 60 health care services stocks in one narrow corner of the market. In the prospectus as of December 31, 2025, its average annual returns were 18.74% over 1 year, 2.27% over 5 years and 6.93% over 10 years. It lost 19.86% in 2022, and its deepest drop took about 47 months to recover. It yields very little.
What's the difference between XHS and IHF?
Both focus on U.S. health care providers, and about 39% of their holdings overlap. XHS weights roughly 60 stocks about equally and charges 0.35%. IHF charges 0.40%. IHF is much larger, with about $1.18 billion in net assets compared with about $140 million for XHS as of June 30, 2026. As of October 27, 2026, XHS returned 33.7% over one year against 16.5% for IHF. Over three years it returned 22.1% a year against 7.7%.
Does XHS pay dividends?
Yes. XHS pays dividends quarterly, but the amounts are small. Over the trailing 12 months it paid about $0.21 per share, a yield of 0.15% as of October 27, 2026. For most holders, nearly all of the return has come from price changes rather than income. Investors who need regular cash from their portfolio would get very little of it here.
What is the XHS expense ratio?
XHS charges 0.35% a year, all of it the management fee, with no fee waiver, according to the prospectus filed October 26, 2026. In the SEC's standard example, $10,000 earning 5% a year would cost about $36 after one year, $197 after five and $443 after ten. That is slightly above the 0.31% average of its compared peers. It ranks 4th of 7 on cost.
What are XHS's top holdings?
As of June 30, 2026, the largest holdings were LifeStance Health Group (2.2%), Hinge Health (2.16%), NeoGenomics (2.09%), GeneDx (2.04%), Hims & Hers Health (2.02%) and PACS Group (2.01%). The top 10 made up just 20.35% of the fund. Because the index resets to roughly equal weights every quarter, the names at the top of the list can change often. No single company dominates.